We are very pleased that justice has been achieved for our members and the physicians, pharmacists and staff who care for them.
Kaiser Permanente, along with the rest of the medical world, relied on the published science about Neurontin’s effectiveness, not knowing it had been wrongfully manipulated. As a result, we ultimately spent more than one hundred million dollars on a very expensive drug that we now know is no more effective than a placebo for pain, bipolar, and many other conditions it was promoted to relieve.
This jury’s decision is a victory for evidence-based medicine. We hope this decision will send a message to the medical community and pharmaceutical industry that manufacturers must adhere to high ethical and legal standards in their research and marketing of drugs.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.